Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program

被引:36
|
作者
Wang, Jiangrong [1 ]
Elfstrom, K. Miriam [2 ,3 ]
Andrae, Bengt [1 ,4 ]
Kleppe, Sara Nordqvist [2 ]
Ploner, Alexander [1 ]
Lei, Jiayao [1 ]
Dillner, Joakim [2 ,5 ]
Sundstrom, Karin [2 ]
Sparen, Par [1 ]
机构
[1] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden
[2] Karolinska Inst, Dept Lab Med, Stockholm, Sweden
[3] Reg Canc Ctr Stockholm Gotland, Stockholm, Sweden
[4] Uppsala Univ Reg Gavleborg, Ctr Res & Dev, Gavle, Sweden
[5] Karolinska Univ Hosp, Karolinska Univ Lab, Stockholm, Sweden
关键词
cervical screening; cytology; cervical cancer; prevention; NORDIC COUNTRIES; UTERINE CERVIX; FOLLOW-UP; POPULATION; CARCINOMA; TRENDS; RISK; ADENOCARCINOMAS; MORTALITY; WOMEN;
D O I
10.1002/ijc.32416
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our study used a refined case-control cervical cancer Audit framework to investigate effectiveness of cervical screening, with measures of three screening failures: irregular-participation, cervical cancer developed after cytological abnormalities and after normal screening results. The register-based study included 4,254 cervical cancer cases diagnosed in Sweden during 2002-2011, and 30 population-based controls per case. We used conditional logistic regression models to examine relative risks of cervical cancer in relation to screening participation and screening results in the past two screening rounds from 6 months before cancer diagnosis. We found that women unscreened in past two screening rounds showed four times increased risk of cervical cancer compared to women screened in time (OR = 4.1, 95% CI = 3.8-4.5), and women unscreened in the previous round but screened in the most recent round also showed a statistically significantly elevated risk (OR = 1.6, 95% CI = 1.5-1.8). Women having abnormality in previous two rounds exhibited higher risk of cervical cancer compared to women screened with normal results, while having normal results in the subsequent round after the abnormality also yielded an increased risk (OR = 4.0, 95% CI = 3.2-5.1). Being screened with only normal results was associated with 89% risk reduction for squamous cell cancer, compared to women unscreened, but only 60% reduction for adenocarcinoma. Our findings emphasize the importance of routine participation in cervical screening and suggest that management of abnormalities, as well as sensitivity of the test, warrants improvement especially for preventing cervical adenocarcinoma. The Audit framework serves as routine evaluation model and the findings benchmark for future evaluation of changes in screening practice.
引用
收藏
页码:1230 / 1240
页数:11
相关论文
共 50 条
  • [1] Effectiveness of the cervical cancer prevention programme: a case-control mortality audit in Lithuania
    Everatt, Ruta
    Kuzmickiene, Irena
    Intaite, Birute
    Anttila, Ahti
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2020, 29 (06) : 504 - 510
  • [2] Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study
    Landy, Rebecca
    Pesola, Francesca
    Castanon, Alejandra
    Sasieni, Peter
    BRITISH JOURNAL OF CANCER, 2016, 115 (09) : 1140 - 1146
  • [3] Effectiveness of Cervical Testing in and outside a Screening Program-A Case-Control Study
    Pankakoski, Maiju
    Sarkeala, Tytti
    Anttila, Ahti
    Heinavaara, Sirpa
    CANCERS, 2022, 14 (21)
  • [4] Impact of screening on cervical cancer incidence: A population-based case-control study in the United States
    Landy, Rebecca
    Sasieni, Peter D.
    Mathews, Christopher
    Wiggins, Charles L.
    Robertson, Michael
    McDonald, Yolanda J.
    Goldberg, Daniel W.
    Scarinci, Isabel C.
    Cuzick, Jack
    Wheeler, Cosette M.
    Joste, Nancy E.
    Kinney, Walter
    McDonald, Ruth M.
    Waxman, Alan
    Jenison, Steven
    Gage, Julia C.
    Castle, Philip E.
    Benard, Vicki
    Saslow, Debbie
    Kim, Jane J.
    Stoler, Mark H.
    Pressley, Giovanna Rossi
    English, Kevin
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (03) : 887 - 896
  • [5] Evaluation of the nationwide cervical screening programme in Thailand: a case-control study
    Kasinpila, Chananya
    Promthet, Supannee
    Vatanasapt, Patravoot
    Sasieni, Peter
    Parkin, D. Maxwell
    JOURNAL OF MEDICAL SCREENING, 2011, 18 (03) : 147 - 153
  • [6] Effectiveness of an organized cervical cancer screening program in Korea: Results from a cohort study
    Jun, Jae Kwan
    Choi, Kui Son
    Jung, Kyu Won
    Lee, Hoo-Yeon
    Gapstur, Susan M.
    Park, Eun-Cheol
    Yoo, Keun-Young
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (01) : 188 - 193
  • [7] Results from a cervical cancer screening program in Samsun, Turkey
    Arslan, Hatice Nilden
    Oruc, Muhammet Ali
    BMC WOMENS HEALTH, 2022, 22 (01)
  • [8] The association between cervical cancer screening and mortality from cervical cancer: A population based case-control study
    Vicus, Danielle
    Sutradhar, Rinku
    Lu, Yan
    Elit, Laurie
    Kupets, Rachel
    Paszat, Lawrence
    GYNECOLOGIC ONCOLOGY, 2014, 133 (02) : 167 - 171
  • [9] Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study
    Chiang, Ying-Cheng
    Chen, Yun-Yuan
    Hsieh, Shu-Feng
    Chiang, Chun-Ju
    You, San-Lin
    Cheng, Wen-Fang
    Lai, Mei-Shu
    Chen, Chi-An
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2017, 56 (04): : 442 - 448
  • [10] Why does cervical cancer occur in a state-of-the-art screening program?
    Castle, Philip E.
    Kinney, Walter K.
    Cheung, Li C.
    Gage, Julia C.
    Fetterman, Barbara
    Poitras, Nancy E.
    Lorey, Thomas S.
    Wentzensen, Nicolas
    Befano, Brian
    Schussler, John
    Katki, Hormuzd A.
    Schiffman, Mark
    GYNECOLOGIC ONCOLOGY, 2017, 146 (03) : 546 - 553